Serum Institute, Verity Pharma apply to distribute Covishield in Canada

Serum Institute, Verity Pharma apply to distribute Covishield in Canada

Verity Pharmaceuticals and Serum Institute of India (SII) have applied to distribute Covishield, SII’s licensed version of AstraZeneca’s COVID-19 vaccine, in Canada as European manufacturing sites struggle to meet global demand. SII, the world’s largest vaccine maker, can produce around 24 lakh doses per day. Earlier, SII helped AstraZeneca fulfil some orders in South Africa, Brazil and others.

News source : Reuters

Leave a Reply

Your email address will not be published.